Tag: British Columbia

  • Brain Star Award winner profile by the Canadian Association for Neuroscience

    Dr. Jacob Stubbs, University of British Columbia

    Scientific publication

    Stubbs JL, Taylor JJ, Siddiqi SH, Schaper FLWVJ, Cohen A, Drew W, Hanlon CA, Abdolahi A, Wang HZ, Honer WG, Panenka WJ, Fox MD. (2023). Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network. Nature Mental Health, 1(10), 772-781.

    https://www.nature.com/articles/s44220-023-00128-7

    Substance use disorders are associated with brain abnormalities that can be identified using non-invasive brain imaging. However, decades worth of brain imaging studies have produced conflicting and heterogeneous findings about what brain regions are implicated in substance use disorders. In their recent study published in Nature Mental Health, Dr. Jacob Stubbs and colleagues investigated whether these heterogenous neuroimaging findings are part of a common brain network.

    The team used a recently developed approach called “network mapping” to evaluate whether seemingly unrelated brain abnormalities in substance use disorder are part of a common brain network. Focusing on data from 144 previous studies and nearly 10,000 participants, they used a connectome as an “average wiring diagram,” to find links between these previously conflicting findings.

    The team showed that more than 90% of previous study findings are linked to a common brain network. They found that this network was consistent across different types of neuroimaging modalities and across different substances of use. They also integrated sources of causal data derived from brain lesions, finding that lesions that disrupt substance use disorders preferentially intersect this novel brain network.

    Overall, the study has both scientific and clinical implications. First, this work provides a common link between decades worth of heterogeneous and conflicting findings from previous studies on neuroimaging in substance use disorder. The work is complementary to previous findings and shifts our understanding of brain abnormalities in substance use disorder from a focus on single brain regions to a unified brain network. Second, this work provides a consistent and specific brain network that can be targeted therapeutically. The peaks of the network align with several cortical targets that can be targeted with non-invasive brain stimulation techniques such as transcranial magnetic stimulation. The study is being used to inform therapeutic targets for substance use disorders in upcoming exploratory and clinical trials on the treatment of substance use disorder.

    Stubbs and colleagues published this study in Nature Mental Health in 2023. It was featured in press releases by the National Institutes of Health and Brigham and Women’s Hospital, as well as in media outlets including Popular Science and the American Academy of Neurology Podcast.

    About Jacob Stubbs

    Dr. Stubbs completed this work while he was a PhD Candidate at the University of British Columbia and collaborating as a Visiting Scholar at Brigham and Women’s Hospital in Boston, USA. He led all aspects of the study, in collaboration with investigators from Brigham and Women’s Hospital, Wake Forest School of Medicine, Rochester Medical Center, Philips Healthcare, and the University of British Columbia. Dr. Stubbs is now a medical student at the University of British Columbia.

    Sources of funding

    Jacob L. Stubbs was supported by a Canadian Institutes of Health Research Vanier Scholarship and a University of British Columbia Friedman Award for Scholars in Health


  • Published October 25, 2023 on the Djavad Mowafaghian Centre for Brain Health website

    The swelling of neurons in the brain is triggered by conditions like stroke or traumatic brain injury. Neuron swelling can cause these cells to die, resulting in extensive brain damage and even death. But until now, it hasn’t been clear what causes the death of neurons during injury-induced swelling.

    Now, in a paper recently published in Cell Reports, Dr. Brian MacVicar and his team provide new evidence for the mechanisms of neuronal death by examining the role that a channel called Pannexin-1 (Panx1) plays in this process. This follows the first demonstration over 20 years ago in Dr. MacVicar’s lab of the involvement of Panx1 in contributing to the death of brain cells in stroke (Science 2006) and seizures (Science 2008).

    Dr. MacVicar and his team found that the swelling of neurons generates oxidative stress, which is a harmful chemical reaction in the cells that triggers Panx1 channels to open and can then lead to the death of brain cells.

    “However, Panx1 has a double-edged role because while it can kill the neuron, it also triggers a protective response,” says Dr. Nicholas Weilinger, a research associate in the MacVicar lab and the paper’s lead author. “Panx1 channels release a molecule called ATP, which is like a ‘help me’ signal drawing microglia to the swollen nerve cells.”

    Microglia are immune cells in the brain. With finger-like projections that are constantly surveying the environment around them, they are part of the brain’s defense mechanisms and act like first responders to protect against harm.

    “It’s been described as a soothing touch,” Dr. MacVicar explains. “When microglial cells touch the nerve cell, it repairs and protects the neuron from dying.”

    In this study, researchers used a combination of electrophysiology to record electrical activity in neurons and two-photon laser microscopy to image the structure of nerve cells, which is important for quantifying how cells swell over time and also to observe how microglia respond.

    When considering potential therapeutic targets, Dr. Weilinger notes that if Panx1 channels could be blocked from opening and causing the initial death process in the first place, this would mean that the microglia would not need to be called upon to save the cell. This is the quicker and more ideal intervention and holds a lot of promise down the road for translational medicine.

    “On the other hand, one of the biggest outstanding questions is how the protective aspect of the microglia-neuron interaction takes place,” says Dr. Weilinger. “If we knew how the microglia were exerting its protective effect, then we could try to amplify this process to improve its healing power. This would be a huge breakthrough for many neurological disorders.”

    To illustrate the devastating effects of brain swelling, Dr. MacVicar notes the example of race car driver Michael Schumacher, who suffered a traumatic brain injury due to a skiing accident in 2013. He had to undergo various surgeries and was also placed in a medically induced coma to reduce pressure and prevent his brain from further swelling.

    “Current treatments for brain swelling are morbid and they only attempt to alleviate the swelling but don’t address the initial cause of the swelling,” says Dr. MacVicar. “So ultimately, if we can prevent neuron swelling in the first place, then we can prevent brain cell death.”


  • Alzheimer’s is a complex neurodegenerative disease affecting millions of people worldwide. Yet despite extensive research, our understanding of why the disease leads to cognitive decline and memory loss remains incomplete. Now, researchers in the University of Victoria’s Division of Medical Sciences have published an article in Nature Communications that could critically improve our understanding of what causes Alzheimer’s disease.

    Many well-accepted explanations of the disease include oxidative stress, inflammation, and the buildup of protein clumps (e.g., of amyloid-beta and tau). However, in the new paper, first-author and MSc student Victor Lau (Tremblay Lab), Dr. Leanne Ramer (Simon Fraser University), and senior author Dr. Marie-Ève Tremblay propose a new hypothesis: the progression of Alzheimer’s disease must involve maladaptive, senescent cell buildup.

    Read the full story on the University of Victoria website


  • In this episode of Brain Bytes we meet with Aarthi Gobinath, PhD. She was curious about what depression looks like in the female brain and how postpartum depression manifests itself. She hopes her work can tackle the issue of researchers commonly using only male test subjects in their studies. Links: Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression. https://www.ncbi.nlm.nih.gov/pubmed/2… Follow Brain Bytes on Twitter! @UBCBrainBytes https://twitter.com/UBCBrainBytes Aarthi Gobinath on Twitter: @aarthigobinath https://twitter.com/aarthigobinath Michael Ruffolo on Twitter: @mike_ruffolo https://twitter.com/mike_ruffolo Brain Bytes is a science communication initiative by graduate students within the Neuroscience Program at the University of British Columbia, in collaboration with the Graduate School of Journalism.


  • On April 15, 2023, neuroscientists at the Djavad Mowafaghian Centre for Brain Health showcased their research in areas such as healthy aging, dementia, mental health, brain injury, Parkinson’s disease and autism, highlighting ways UBC is leading the way in improving the lives of British Columbians and what some of the next discoveries in brain health might be.

    Speakers:

    • Drs. Lynn Raymond and Shernaz Bamji (Overview of the Centre)
    • Dr. Teresa Liu-Ambrose (Healthy Aging)
    • Dr. Mark Cembrowski (Learning/Memory and Dementias)
    • Dr. Cheryl Wellington (Brain Injury and Repair)
    • Dr. Fidel Vila-Rodriguez (Mental Health and Addictions)
    • Dr. Kurt Haas (Brain Development and Neurodevelopmental Disorders)
    • Dr. Silke Appel-Cresswell (Sensory/Motor Systems and Movement Disorders)